The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Sjögren's Syndrome
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
-
Local Institution - 0222, La Palma, California, United States, 90623
Local Institution - 0218, San Francisco, California, United States, 94143
Providence St. John's Health Center, Santa Monica, California, United States, 90404
Denver Arthritis Clinic, Denver, Colorado, United States, 80230
Clinical Research of West Florida, Inc, Clearwater, Florida, United States, 33765
Local Institution - 0223, Sarasota, Florida, United States, 34239
Augusta University, Augusta, Georgia, United States, 30912
Clinic of Robert Hozman/Clinical Investigation Specialists Inc., Skokie, Illinois, United States, 60076
University of Kansas Medical Center, Kansas City, Kansas, United States, 66160
Local Institution - 0123, Hopkinsville, Kentucky, United States, 42240
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Bristol-Myers Squibb,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2028-11-16